Confidential Treatment of this Agreement Sample Clauses

Confidential Treatment of this Agreement. Each Party may disclose the existence and general nature of this Agreement as permitted by Section 27.8 (Public Disclosures), but otherwise the terms and conditions of this Agreement will be considered the Confidential Information of each Party; provided however, that the terms and conditions may be disclosed by either Party in connection with an actual or good-faith proposed merger, acquisition, or similar transaction, so long as such receiving entity first agrees in writing to obligations substantially similar to those described in this Section 21.
AutoNDA by SimpleDocs
Confidential Treatment of this Agreement. If, at any time, the Company files this Agreement or any portion hereof with the Securities and Exchange Commission, the Company shall be required to cooperate with the Purchaser to apply for, and use reasonable efforts to obtain in advance of such filing, confidential treatment for such portions of the Agreement specified by Purchaser. [The remainder of this page is intentionally left blank.]
Confidential Treatment of this Agreement. Each Party may disclose the existence and general nature of this Agreement as permitted by Section 27.6 (Public Disclosures), but otherwise the terms and conditions of this Agreement will be considered the Confidential Information of each Party; provided however, that this Agreement may be disclosed in its entirety by either Party in connection with an actual or good-faith proposed merger, acquisition, or similar transaction or in connection with due diligence conducted for a securities offering, so long as such receiving entity (unless such party is legal counsel to the counterparty in such transaction) first agrees in writing to obligations substantially similar to those described in this Section 21 (Confidentiality); and provided further that Triple-S may disclose in one or more of its filings with the Securities and Exchange Commission such terms of this Agreement as it believes in good faith to be necessary to ensure that its filings under the Securities Exchange Act of 1934, taken as a whole, do not omit to state a material fact necessary in order to make the statements made in the light of the circumstances under which they were made, not misleading. Furthermore, to the extent Triple-S is required, or elects, to file this Agreement (or any portion thereof) with the Securities and Exchange Commission, Triple-S will (i) provide Supplier with advance written notice prior to making such filing; (ii) take all actions reasonably required to request and obtain confidential treatment of commercially sensitive information contained in this Agreement from the Securities and Exchange Commission; and (iii) work in good faith with Supplier to identify for such purpose such commercially sensitive information
Confidential Treatment of this Agreement. (i) The terms and conditions of this Agreement will be deemed to be the Confidential Information of each party and, except as required to be disclosed by law, will not be disclosed without the consent of the other party; provided that each of the parties may: (A) provide a copy of this Agreement or generally describe this Agreement to any Person with which such party is having bona fide merger, business combination or acquisition discussions; and (B) summarize this Agreement in a prospectus or registration statement filed by such party with any Canadian or U.S. securities regulatory authority. (ii) In the event the Receiving Party is required by Applicable Law or by the terms of any listing agreement to file this Agreement with any governmental agency or in any other public forum, the Receiving Party will use its best efforts to redact from such filing the economic terms contained in this Agreement and such other terms as the Disclosing Party may reasonably request.

Related to Confidential Treatment of this Agreement

  • Confidential Treatment The parties hereto understand that any information or recommendation supplied by the Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Investment Manager, the Company or such persons the Investment Manager may designate in connection with the Fund. The parties also understand that any information supplied to the Sub-Adviser in connection with the performance of its obligations hereunder, particularly, but not limited to, any list of securities which may not be bought or sold for the Fund, is to be regarded as confidential and for use only by the Sub-Adviser in connection with its obligation to provide investment advice and other services to the Fund.

  • CONFIDENTIAL TREATMENT REQUESTED Confidential portions of this document have been redacted and have been separately filed with the Commission.

  • Medical Treatment Undersigned understands that the Released Parties do not have medical personnel available at the location of the activities. Undersigned hereby grants the Released Parties permission to administer first aid or to authorize emergency medical treatment, if necessary. Undersigned understands and agrees that any such action by the Released Parties shall be subject to the terms of this agreement and release, including any liability arising from the negligence of the Released Parties when administering first aid or authorizing others to do so. Undersigned understands and agrees that the Released Parties do not assume responsibility for any injury or damage which might arise out of or in connection with such authorized emergency medical treatment.

  • Securities Sold Pursuant to this Agreement The Securities have been duly authorized and reserved for issuance and when issued and paid for in accordance with this Agreement, will be validly issued, fully paid and non-assessable; the holders thereof are not and will not be subject to personal liability by reason of being such holders; the Securities are not and will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company; and all corporate action required to be taken for the authorization, issuance and sale of the Securities has been duly and validly taken. The form of certificates for the Securities conform to the corporate law of the jurisdiction of the Company’s incorporation and applicable securities laws. The Securities conform in all material respects to the descriptions thereof contained in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus, as the case may be. When paid for and issued, the Warrants will constitute valid and binding obligations of the Company to issue the number and type of securities of the Company called for thereby in accordance with the terms thereof and such Warrants are enforceable against the Company in accordance with their respective terms, except: (i) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally; (ii) as enforceability of any indemnification or contribution provision may be limited under foreign, federal and state securities laws; and (iii) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought. The shares of Common Stock issuable upon exercise of the Warrants have been reserved for issuance upon the exercise of the Warrants and upon payment of the consideration therefor, and when issued in accordance with the terms thereof such shares of Common Stock will be duly and validly authorized, validly issued, fully paid and non-assessable, and the holders thereof are not and will not be subject to personal liability by reason of being such holders.

  • CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION Schedule A to Arbitration Agreement

  • No Consideration Absent Execution of this Agreement Employee understands and agrees that Employee would not receive the monies and/or benefits specified in paragraph “2” above, except for Employee’s execution of this Agreement and the fulfillment of the promises contained herein.

  • Terms of this Agreement The Parties acknowledge that this Agreement and all of the respective terms of this Agreement shall be treated as Confidential Information of both Parties.

  • Confidential Terms Except as expressly provided herein, each party agrees not to disclose any terms of this Agreement to any third party without the consent of the other party, except as required by securities or other applicable laws, to prospective and other investors and such party’s accountants, attorneys and other professional advisors.

  • Emergency Medical Treatment I grant the Releasees permission to authorize emergency medical treatment as they deem appropriate, and agree that such action by the Releasees shall be subject to the terms of this Agreement. I understand and agree that the Releasees assume no responsibility for any injury or damage that might result from such emergency medical treatment.

  • CONFIDENTIAL/TRADE SECRET MATERIALS a. Contractor Confidential, trade secret or proprietary materials as defined by the laws of the State of New York must be clearly marked and identified as such upon submission by the Bidder. Marking the Bid as “confidential” or “proprietary” on its face or in the document header or footer shall not be considered by the Commissioner or Authorized User to be sufficient without specific justification as to why disclosure of particular information in the Bid would cause substantial injury to the competitive position of the Bidder. Bidders/Contractors intending to seek an exemption from disclosure of these materials under the Freedom of Information Law must request the exemption in writing, setting forth the reasons for the claimed exemption. Acceptance of the claimed materials does not constitute a determination on the exemption request, which determination will be made in accordance with statutory procedures. Properly identified information that has been designated confidential, trade secret, or proprietary by the Bidder will not be disclosed except as may be required by the Freedom of Information Law or other applicable State and federal laws.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!